A Retrospective Cohort Study of the Clinical Presentation and Visual Outcomes of Blepharoptosis Treatment

Blepharoptosis (ptosis) is the drooping of the upper eyelid, which can be congenital or acquired and caused by various factors. It can lead to vision impairment, such as amblyopia in children, and reduced visual fields in adults, affecting quality of life.

To analyze the clinical manifestation of ptosis, specifically examining the available treatment options and evaluating the resulting visual outcomes.

A comprehensive analysis was conducted on the medical records of patients diagnosed with ptosis who received treatment through both surgical and non-surgical approaches between January 2017 and December 2020. Additionally, an examination of the underlying factors contributing to the condition was performed and presented.

A total of 28 patients, with an average age of 31.48 ± 21.66 years, received treatment at our facilities. Out of the 26 cases of unilateral ptosis, 11 patients (43%) underwent surgery, while 15 patients (57%) were treated with medications. The majority of the surgical cases were due to congenital ptosis (8 patients), followed by traumatic ptosis (3 patients). Among the patients who did not undergo surgery, neurological ptosis was present in 6 cases, while congenital ptosis was observed in 5 cases. All cases were successfully managed, resulting in good visual acuity and no complications.

The most prevalent type of ptosis is congenital ptosis, which primarily affects males and tends to occur more frequently in the left eye. In acquired cases, traumatic ptosis is the most commonly observed type according to this study. After undergoing surgery, patients with congenital ptosis experienced improved visual outcomes, displaying good cosmetic appearance and achieving a visual acuity of 6/6-6/18.